The Central government on Thursday, May 28 lifted restrictions on the export of highly demanded paracetamol APIs. India had earlier imposed curbs on the export of several active pharmaceutical ingredients (API) to avoid shortage at home.
"The notification dated 03.03.2020 is further amended to remove the restriction on the export of Paracetamol APIs, making it export ''free'' with immediate effect," said a statement from the Directorate General of Foreign Trade (DGFT).
On March 6, Union Minister of State for Shipping and Chemical and Fertilisers Mansukh Mandaviya had imposed curbs on the export of several active pharmaceutical ingredients (API) and formulations made from these APIs including paracetamol, and tinidazole, on concerns of a shortage of drugs in the country.
In April, India had temporarily licensed the export of paracetamol and anti-malarial drug Hydroxychloroquine (HCQ) in appropriate quantities to countries severely affected by the coronavirus pandemic, becoming the major exporter of the anti-malarial drug.
(With inputs from agencies)